No Data
No Data
Express News | Kexing Biopharm: The upper limit of the repurchase price has been adjusted to 46.83 yuan per share.
Kexing Biopharm (688136.SH): has repurchased a total of 0.1047 million shares of the company.
On May 7, Gelonghui reported that Kexing Biopharm (688136.SH) announced that as of April 30, 2025, the company had repurchased a total of 104,653 shares through the trading system of the Shanghai Exchange via centralized bidding, accounting for 0.05% of the company's current total share capital. The highest transaction price was 23.55 yuan/share, and the lowest price was 23.14 yuan/share, with a total payment of 2,439,224.76 yuan (excluding trading commissions and other fees).
Express News | Kexing Biopharm has reached a Global Strategy cooperation with Zhejiang Tianyu Pharmaceutical.
Kexon Pharmaceuticals: Report for the first quarter of 2025
2025 First Quarter Report
Express News | Kexing Biopharm: In the first quarter, the Net income was 25.5772 million yuan, a year-on-year increase of 106.21%.